Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 November 2019 | Story Leonie Bolleurs | Photo Leonie Bolleurs
Farmovs
At a first for South Africa, the SACRA clinical trials capacity-building workshop with government, research institutions, and industry, were from the left: Dr Nathaniel Mofolo, Dr Rita Nathan, Dr Mojalefa Maseloa (Head: Clinical Services in the Clinical Unit at the Universitas Hospital) and Sue Baily (Site Management Head at IQVIA).

Whether it is to treat the flu or a more serious illness, all medicines go through a very costly and lengthy research process before being approved for prescription to patients. The cumulative time from the beginning of trials to marketing approval has increased over the past ten years. 

According to Dr Vathi Papu-Zamxaka from the South African Clinical Research Association (SACRA), South Africans would not have had access to safe and effective medicines, had it not been for the intensive research conducted on new medicines. 

On 7 November 2019, a group of 115 delegates representing the Free State Department of Health, the UFS, private research sites, and the pharmaceutical industry met at FARMOVS on the Bloemfontein Campus of the University of the Free State (UFS) for the SACRA clinical trials capacity-building workshop.

2,1 billion dollars to develop one successful drug

Dr Michelle Middle, Chief Medical Officer at FARMOVS, provided some interesting stats on the process for drugs to hit the shelves: “One out of 10 drugs entering human research will be approved. The cost of development of one successful drug is approximately 2,1 billion dollars. And the time to develop a drug, from submission of the Investigational New Drug Application (IND) to approval by the Food and Drug Administration (FDA), is between 12 and 15 years.”

Dr Middle stated that drug development is one of the most regulated processes, with ethics and patient safety governing the undertaking. “With SAHPRA (South African Health Products Regulatory Agency) having some of the strictest regulations in the world, South Africa has a good history of running trials.  In addition, fast growth is expected for the pharmaceutical market on the African continent, necessitating the need for increased clinical trials on this continent,” she said. 

Very few clinical trials hosted in South Africa 

Although Africa has the broadest genetic variability of all human populations and carries 17% of the global population, very few clinical trials are hosted on the continent. Globally, there are currently approximately 322 000 clinical trials being actively conducted, of which only 1 700 are conducted in Africa, i.e. less than 3%.  Even worse, only 304 of the 1 700 trials running in Africa are conducted in South Africa.  There is thus a critical need for South Africa as a country to market itself as a clinical trial destination and to attract more trials to the country.

South Africa’s competitive edge lies in being known for its ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use)-compliant top-quality research, racial and genetic diverse trial participants, good medical infrastructure and expertise, and the good reputation of the regulator (SAHPRA). “There are, however, a need for transformation and capacity building in clinical research in the country,” said Dr Middle. 

Dr Rita Nathan, Head of Clinical Services in the Clinical Department at the Universitas Hospital, who was representing government at the workshop, is looking to strengthen clinical trials across government and industry by focusing on, among others, funding models, operations management, and service delivery. 

From the UFS Faculty of Health Sciences, Dr Nathaniel Mofolo, Head of the School of Clinical Medicine, said collaboration between stakeholders is important. “This initiative is giving direction to the UFS vision of being a research-led university.” 

Other topics discussed at the workshop include the clinical trials landscape, how clinical trials work, the patient factor, ethics in clinical trials, and the economic aspect of clinical trials. 

News Archive

UFS scoops up MACE special award for consistent excellence
2016-12-02

Description: MACE awards 2016 Tags: MACE awards 2016 

From the left: Martie Nortjé, Lerato Sebe, Thabo Kessah,
Lacea Loader, Lelanie de Wet, Leonie Bolleurs,
Leslé-Ann George, and Mamosa Makaya from the
UFS Communication and Brand Management team
at the MACE Excellence Awards, where they received
two Merit Awards, two Excellence Awards, four Gold Awards,
one Platinum Award, and one Severus Cerff: Special Award.

The Department of Communication and Brand Management at the University of the Free State (UFS) won ten awards during the Excellence Awards of the national association of Marketing, Advancement, and Communication in Education (MACE), held on 24 November 2016 in Cape Town. Hundred and sixty two awards were presented at the event.

At the awards ceremony, the department further received the Severus Cerff Award for demonstrating consistent and outstanding excellence in the 2016 Excellence Awards Programme.

The awards ceremony is part of the MACE Annual National Congress, which took place from 23 to 25 November 2016. The MACE Congress is a platform where experts from the fields of marketing, advancement, and communication share experiences and best practices. This year’s programme included speakers such as Dr Imtiaaz Sooliman, Founder of Gift of the Givers, Ruda Landman, Non-Executive Director of Media24 Limited, and Jonathan Shapiro, well-known cartoonist.

Lacea Loader, Director of the Department of Communication and Brand Management, said, “I am extremely proud of our achievements and I’m privileged to work with such a high-performing team. The fact that we received the Severus Cerff Award for consistent excellence is an additional, exceptional accomplishment.”

Other awards include a Platinum Award, four Gold Awards, two Excellence Awards, and two Merit Awards. Martie Nortjé, Assistant Director: Branding and Merchandise, received a Platinum Award for KovsieGear, the university’s merchandise shop. The Platinum Award is given to all the entries receiving a Gold Award of Excellence in a category, and the best entry in a division receives the award.

Leonie Bolleurs, Assistant Director: Internal Communication, received the Gold Awards for the Sound [W]right UFS student tone and voice guide, the Spaces and Places Video, the Student Bursary Fund Campaign: Photographs as well as the Excellence Awards for the Student Bursary Fund Campaign: Video and the Expanded Footprints Publication. Loader was awarded with the Gold Award for the Facilitation of the review of the UFS Language Policy. This award is given to the highest-scoring entry in every category.

Thabo Kessah, Senior Officer: Internal Communication at the Qwaqwa Campus, and Loader each received a Merit Award for the Ke Eo Taba Qwaqwa Newsletter and Prof Jonathan Jansen’s Commemorative Book: For such a time as this.

Earlier this year, KovsieGear received Gold at the 2016 Prism Awards of the Public Relations Institute of Southern Africa (PRISA). The B Safe Take Action campaign also recently received an award at the African Excellence Awards in Cape Town.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept